MiR-130a in the adipogenesis of human SGBS preadipocytes and its susceptibility to androgen regulation

References

• Roelen BAJ, Dijke PT. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci. 2003;8(5):740–748.
   PubMedGoogle Scholar
• Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets. 2011;15(5):623–636.
   PubMed Web of Science ®Google Scholar
• Fajas L, Debril MB, Auwerx J. PPAR gamma: an essential role in metabolic control. Nutr Metab Cardiovas Dis. 2001;11(1):64–69.
   Google Scholar
• Lefterova MI, Haakonsson AK, Lazar MA, et al. PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 2014;25(6):293–302.
   PubMed Web of Science ®Google Scholar
• Prestwich TC, Macdougald OA. Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol. 2007;19(6):612–617.
   PubMed Web of Science ®Google Scholar
• Tang -Q-Q, Otto TC, Lane MD. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA. 2003;100(3):850–855.
   PubMed Web of Science ®Google Scholar
• Kennell JA, Macdougald OA. Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J Biol Chem. 2005;280(25):24004–24010.
   PubMed Web of Science ®Google Scholar
• Li Y, Jin D, Xie W, et al. PPAR-γ and Wnt regulate the differentiation of MSCs into adipocytes and osteoblasts respectively. Curr Stem Cell Res Ther. 2018;13(3):185–192.
   PubMed Web of Science ®Google Scholar
• He H, Chen K, Wang F, et al. miR-204-5p promotes the adipogenic differentiation of human adipose-derived mesenchymal stem cells by modulating DVL3 expression and suppressing Wnt/β-catenin signaling. Int J Mol Med. 2015;35(6):1587–1595.
   PubMed Web of Science ®Google Scholar
• Shi C, Zhang M, Tong M, et al. miR-148a is associated with obesity and modulates adipocyte differentiation of mesenchymal stem cells through Wnt signaling. Sci Rep. 2015;5:9930.
   PubMed Web of Science ®Google Scholar
• Shuai Y, Yang R, Mu R, et al. MiR-199a-3p mediates the adipogenic differentiation of bone marrow-derived mesenchymal stem cells by regulating KDM6A/WNT signaling. Life Sci. 2019;220:84–91.
   PubMed Web of Science ®Google Scholar
• Karbiener M, Fischer C, Nowitsch S, et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun. 2009;390(2):247–251.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen Y, Zhang S, et al. MiR-540 as a novel adipogenic inhibitor impairs adipogenesis via suppression of PPARγ. J Cell Biochem. 2015;116(6):969–976.
   PubMed Web of Science ®Google Scholar
• John E, Wienecke-Baldacchino A, Liivrand M, et al. Dataset integration identifies transcriptional regulation of microRNA genes by PPARγ in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res. 2012;40(10):4446–4460.
   PubMed Web of Science ®Google Scholar
• Yu J, Kong X, Liu J, et al. Expression profiling of PPARγ-regulated microRNAs in human subcutaneous and visceral adipogenesis in both genders. Endocrinology. 2014;155(6):2155–2165.
   PubMed Web of Science ®Google Scholar
• Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009;5(12):673–681.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Morelli A, et al. Hypogonadism and metabolic syndrome. J Endocrinol Invest. 2011;34(7):557–567.
   PubMed Web of Science ®Google Scholar
• Grossmann M. Hypogonadism and male obesity: focus on unresolved questions. Clin Endocrinol. 2018;89(1):11–21.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999;84(8):2647–2653.
   PubMed Web of Science ®Google Scholar
• Behre HM, Tammela TLJ, Arver S, et al. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male. 2012;15(4):198–207.
   PubMed Web of Science ®Google Scholar
• Singh R, Artaza JN, Taylor WE, et al. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology. 2003;144(11):5081–5088.
   PubMed Web of Science ®Google Scholar
• Singh R, Artaza JN, Taylor WE, et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology. 2006;147(1):141–154.
   PubMed Web of Science ®Google Scholar
• Gupta V, Bhasin S, Guo W, et al. Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol. 2008;296(1–2):32–40.
   PubMed Web of Science ®Google Scholar
• Chazenbalk G, Singh P, Irge D, et al. Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids. 2013;78(9):920–926.
   PubMed Web of Science ®Google Scholar
• Vimalraj S, Selvamurugan N. MicroRNAs expression and their regulatory networks during mesenchymal stem cells differentiation toward osteoblasts. Int J Biol Macromol. 2014;66:194–202.
   PubMed Web of Science ®Google Scholar
• Zhang H-D, Jiang L-H, Sun D-W, et al. The role of miR-130a in cancer. Breast Cancer. 2017;24(4):521–527. (Tokyo, Japan)
   PubMed Web of Science ®Google Scholar
• Ni Z, Shang XF, Wang YF, et al. Upregulated microRNA-301a in osteosarcoma promotes tumor progression by targeting CDC14A. Genet Mol Res. 2016;15(2):gmr7807.
   Web of Science ®Google Scholar
• Baranwal S, Rawat SG, Gupta P. miR-301, pleiotropic microRNA in regulation of inflammatory bowel disease and colitis-associated cancer. Front Immunol. 2018;9:522.
   PubMed Web of Science ®Google Scholar
• Wabitsch M, Brenner RE, Melzner I, et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 2001;25(1):8–15.
   PubMed Web of Science ®Google Scholar
• Kraus M, Greither T, Wenzel C, et al. Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgen-regulated microRNA miR-375. Mol Cell Endocrinol. 2015;414:177–185.
   PubMed Web of Science ®Google Scholar
• Seenprachawong K, Tawornsawutruk T, Nantasenamat C, et al. miR-130a and miR-27b enhance osteogenesis in human bone marrow mesenchymal stem cells via specific down-regulation of peroxisome proliferator-activated receptorγ. Front Genet. 2018;9:543.
   PubMed Web of Science ®Google Scholar
• Lin Z, He H, Wang M, et al. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate. Cell Prolif. 2019;52(6):e12688.
   PubMed Web of Science ®Google Scholar
• Xu N, Shen C, Luo Y, et al. Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun. 2012;425(2):468–472.
   PubMed Web of Science ®Google Scholar
• Lee SH, Jung YD, Choi YS, et al. Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget. 2015;6(32):33269–33278.
   PubMedGoogle Scholar
• Xian X, Tang L, Wu C, et al. miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/β-catenin signaling pathway in gastric carcinoma. Onco Targets Ther. 2018;11:7503–7512.
   PubMed Web of Science ®Google Scholar
• Takayama K-I, Misawa A, Inoue S. Significance of microRNAs in androgen signaling and prostate cancer progression. Cancers (Basel). 2017;9(8):E102.
   PubMed Web of Science ®Google Scholar
• Boll K, Reiche K, Kasack K, et al. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene. 2013;32(3):277–285.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu H, Li P, et al. NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells. J Transl Med. 2014;12:155.
   PubMed Web of Science ®Google Scholar
• Li C, Yang B, Pan P, et al. MicroRNA-130a inhibits spermatogenesis by directly targeting androgen receptor in mouse Sertoli cells. Mol Reprod Dev. 2018;85(10):768–777.
   PubMed Web of Science ®Google Scholar
• Asukai K, Kawamoto K, Eguchi H, et al. Micro-RNA-130a-3p regulates gemcitabine resistance via PPARG in cholangiocarcinoma. Ann Surg Oncol. 2017;24(8):2344–2352.
   PubMed Web of Science ®Google Scholar
• Wei W, Sun W, Han H, et al. miR-130a regulates differential lipid accumulation between intramuscular and subcutaneous adipose tissues of pigs via suppressing PPARG expression. Gene. 2017;636:23–29.
   PubMed Web of Science ®Google Scholar
• Ma X, Wei D, Cheng G, et al. Bta-miR-130a/b regulates preadipocyte differentiation by targeting PPARG and CYP2U1 in beef cattle. Mol Cell Probes. 2018;42:10–17.
   PubMed Web of Science ®Google Scholar
• Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97(12):E2271–6.
   PubMed Web of Science ®Google Scholar
• Jin F, Xing J. Circulating miR-126 and miR-130a levels correlate with lower disease risk, disease severity, and reduced inflammatory cytokine levels in acute ischemic stroke patients. Neurol Sci. 2018;39(10):1757–1765.
   PubMed Web of Science ®Google Scholar